Paper Review Records
全部论文审稿周期
25 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期；保留 PDF/DOI/网页源链接
421
天
Optimizing Ketamine Infusion Therapy for Treatment‐Resistant Bipolar Depression: Commentary on Zhou et al. (2023)
作者
Chih‐Cheng Lin; Lien‐Chung Wei展开收起
作者单位
1. Department of General Psychiatry Taoyuan Psychiatric Center, Ministry of Health and Welfare Taoyuan City Taiwan (Republic of China); 2. Department of Addiction Psychiatry Taoyuan Psychiatric Center, Ministry of Health and Welfare Taoyuan City Taiwan (Republic of China); 3. Department of Counseling and Industrial/Organizational Psychology Ming Chuan University–Taoyuan Campus Taoyuan City Taiwan展开收起
125
天
A Shift in Trust: An Analysis of the Use of AI Chatbots Among People Living With Bipolar Disorder
作者
Katherine Bassil; Dido Prins; Hine van Os; Georg Starke; Eline de Groot; Annemieke Dols; Edwin van Dellen展开收起
作者单位
1. Department of Bioethics and Health Humanities University Medical Center Utrecht Utrecht the Netherlands; 2. Division Brain, Department of Psychiatry University Medical Center Utrecht Utrecht the Netherlands; 3. Institute of History and Ethics in Medicine Technical University of Munich Munich Germany; 4. Department of Neurology UZ Brussel and Vrije Universiteit Brussel Brussels Belgium展开收起
278
天
State‐Specific Segmental Abnormalities of White Matter Structure and Function in Pediatric Bipolar Disorders
作者
Ziqi Chen; Weijia Gao; Ruhai Dou; Xin Zhang; Zhe Shen; Yongxin Guo; Dong Cui; Guanghui Yu; Weifang Cao; Qing Jiao; Guangming Lu展开收起
作者单位
1. School of Radiology Shandong First Medical University & Shandong Academy of Medical Sciences Tai'an China; 2. Department of Child Psychology, The Children's Hospital Zhejiang University School of Medicine Hangzhou China; 3. Department of Medical Imaging, Jinling Hospital, Clinical School of Medical College Nanjing University Nanjing China展开收起
369
天
Prescription Trends for Bipolar Disorder With and Without Comorbid Substance Use and Anxiety Disorders: A Global Bipolar Cohort Collaborative Study
作者
Anastasia K. Yocum; Martin Alda; Bruno Aouizerate; Valerie Aubin; Frank Bellivier; Raoul Belzeaux; Michael Berk; Joanna M. Biernacka; Monika Budde; Katherine E. Burdick; Yun‐Hsuan Chang; Brandon J. Coombes; Philippe Courtet; Nina Dalkner; Claudia Diaz‐Byrd; Caroline Dubertret; Bruno Etain; Giovanna Fico; Janice M. Fullerton; Ophelia Godin; Katherine Gordon‐Smith; Emmanuel Haffen; Dominique Januel; Kamyar Keramatian; Marion Leboyer; Antoine Lefrere; Pierre‐Michel Llorca; Marzieh Majd; Philip B. Mitchell; Benson Mwangi; Emilie Olie; Bronwyn J. Overs; Joanne Petite; Mircea Polosan; Romain Rey; Gloria Roberts; Paul Roux; Ludovic Samalin; Raymund Schwan; Alessandro Serretti; Jair C. Soares; Sarah H. Sperry; Rebecca Strawbridge; Tatjana Stross; Eduard Vieta; Michel Walter; Lana J. Williams; Mon‐Ju Wu; Lakshmi N. Yatham; Allan H. Young; Antoine Yrondi; Giovana B. Zunta‐Soares; Mark A. Frye; Melvin G. McInnis; Balwinder Singh展开收起
作者单位
1. Department of Psychiatry University of Michigan Ann Arbor Michigan USA; 2. Department of Psychiatry Dalhousie University Halifax Nova Scotia Canada; 3. Fondation FondaMental Creteil France; 4. Centre Hospitalier Charles Perrens, Laboratoire NutriNeuro (UMR INRA 1286), Université de Bordeaux Bordeaux France; 5. Pôle de Psychiatrie Centre Hospitalier Princesse Grace Monaco Monaco; 6. Optimisation Thérapeutique en Neuropharmacologie, Université Paris Cité, INSERM UMRS 1144 Paris France; 7. Département de Psychiatrie et de Médecine Addictologique, Hôpitaux Lariboisière‐Fernand Widal, DMU Neurosciences, AP‐HP.Nord Université Paris Cité Paris France; 8. Department of Psychiatry and Addictology University Hospital Center Montpellier France; 9. IGF, Univ. Montpellier, CNRS, INSERM Montpellier France; 10. Deakin Institute for Mental and Physical Health and Clinical Translation (Deakin IMPACT), School of Medicine Deakin University Melbourne Victoria Australia; 11. Mental Health Drug and Alcohol Services, Barwon Health University Hospital Geelong Geelong Australia; 12. Department of Psychiatry and Psychology Mayo Clinic Rochester Minnesota USA; 13. Department of Quantitative Health Sciences Mayo Clinic Rochester Minnesota USA; 14. Institute of Psychiatric Phenomics and Genomics (IPPG), LMU University Hospital, LMU Medizin Ludwig‐Maximilians‐Universität München Munich Germany; 15. Vagelos College of Physicians and Surgeons Columbia University New York New York USA; 16. New York State Psychiatric Institute New York New York USA; 17. Institute of Gerontology, College of Medicine National Cheng Kung University Tainan Taiwan; 18. Institute of Behavioral Medicine, College of Medicine National Cheng Kung University Tainan Taiwan; 19. Department of Psychology National Cheng Kung University Tainan Taiwan; 20. Department of Emergency Psychiatry and Acute Care CHU Montpellier, IGF, Univ. Montpellier, CNRS, Inserm Montpellier France; 21. Division of Psychiatry and Psychotherapeutic Medicine Medical University of Graz Graz Austria; 22. AP‐HP, Groupe Hospitalo‐Universitaire AP‐HP Nord, DMU ESPRIT, Service de Psychiatrie et Addictologie, Hôpital Louis Mourier, Colombes, France Université de Paris Inserm UMR1266, Sorbonne Paris Cité, Faculté de Médecine Paris France; 23. Bipolar and Depressive Disorders Unit, Institute of Neuroscience, Hospital Clinic University of Barcelona, IDIBAPS, CIBERSAM Barcelona Catalonia Spain; 24. Discipline of Psychiatry and Mental Health, School of Clinical Medicine University of New South Wales Sydney New South Wales Australia; 25. School of Medical Sciences, Faculty of Medicine University of New South Wales Sydney New South Wales Australia; 26. Neuroscience Research Australia Sydney New South Wales Australia; 27. Centre for Mental Health & Brain Sciences, School of Health Sciences Swinburne University of Technology Victoria Australia; 28. Departement Medico‐Universitaire de Psychiatrie et d’Addictologie (DMU IMPACT), Université Paris Est Créteil (UPEC) INSERM, IMRB U955, Laboratoire Neuro‐psychiatrie translationnelle and centre expert Bipolaire AP‐HP, Hopital Henri Mondor Creteil France; 29. BDRN University of Worcester UK; 30. Université Marie et Louis Pasteur, UMR INSERM 1322 LINC, Service de Psychiatrie de L'adulte, CIC‐1431 INSERM Besançon France; 31. Département de Recherche Clinique, pôle Universitaire 93G03, EPS Ville Evrard Neuilly Sur Marne Université Sorbonne Paris‐Nord, Unité Inserm U955 Neuilly‐sur Marne France; 32. Department of Psychiatry University of British Columbia Vancouver British Columbia Canada; 33. Department of Psychiatry, Clermont‐Ferrand University Hospital University of Clermont Auvergne, CNRS, IP, UMR 6602 Clermont‐Ferrand France; 34. Department of Psychiatry Columbia University Irving Medical Center New York New York USA; 35. Department of Psychiatry Brigham and Women's Hospital Boston Massachusetts USA; 36. Department of Psychiatry Harvard Medical School Boston Massachusetts USA; 37. School of Behavioral Health Sciences University of Texas Health Sciences Center at Houston Texas USA; 38. Macquarie Medical School, Faculty of Medicine, Health and Human Sciences Macquarie University Sydney New South Wales Australia; 39. Univ. Grenoble Alpes, Inserm, U1216, CHU Grenoble Alpes, Grenoble Institut Neurosciences Grenoble France; 40. Bipolar Disorder Expert Centre Le Vinatier Hospital Bron France; 41. University Lyon 1 Villeurbanne France; 42. Inserm U1028, CNRS UMR5292, Lyon Neuroscience Research Center Psychiatric Disorders, Neuroscience Research and Clinical Research Team Lyon France; 43. Lyon Neuroscience Research Center, Psychiatric Disorders Neuroscience Research and Clinical Research Team Lyon France; 44. Centre Hospitalier de Versailles Service Universitaire de Psychiatrie D'adulte et D'addictologie Le Chesnay France; 45. Service de Psychiatrie du Secteur 78G18 Centre Hospitalier de Plaisir Plaisir France; 46. DisAP, MOODS Team, INSERM UMR1018, CESP Université de Versailles Saint‐Quentin‐En‐Yvelines ‐ Université Paris‐Saclay Le Chesnay France; 47. Université de Lorraine Nancy France; 48. Centre d'Etudes et de Recherches sur les Services de Santé et qualité de vie CEReSS/EA 3279; Hôpitaux Universitaires de Marseille Marseille France; 49. Department of Medicine and Surgery Kore University of Enna Enna Italy; 50. Oasi Research Institute‐IRCCS Troina Italy; 51. Department of Psychological Medicine Institute of Psychiatry, Psychology & Neuroscience, King's College London London UK; 52. Bipolar and Depressive Disorders Unit Hospital Clínic de Barcelona Barcelona Spain; 53. Fundació Clínic‐Institut D'investigacions Biomèdiques August pi I Sunyer (IDIBAPS) Barcelona Spain; 54. Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM) Instituto de Salud Carlos III Barcelona Spain; 55. CHRU de Brest, Hôpital de Bohars Service Hospitalo‐Universitaire de Psychiatrie Générale et de Réhabilitation Psycho Sociale 29G01 et 29G02 Brest France; 56. Service de Psychiatrie et de Psychologie Médicale Centre Expert Dépression Résistante et Bipolaire FondaMental, CHU de Toulouse, Hôpital Purpan, ToNIC Toulouse NeuroImaging Centre Toulouse France; 57. Université de Toulouse, Inserm, UPS Toulouse France展开收起
698
天
The Relation Between Perceived Social Support, Treatment Adherence and Recovery Among Individuals Diagnosed With Bipolar Disorder
作者
Cemile Hürrem Ayhan; Mehmet Cihad Aktaş; Ramazan Aydar; Sakine Aktaş; Seda Karakaya Cataldas展开收起
作者单位
1. Department of Psychiatric Nursing, Faculty of Health Sciences Van Yüzüncü Yıl University Van Turkey; 2. Department of Psychiatric and Mental Health Nursing, Institute of Health Sciences Van Yüzüncü Yıl University Van Turkey; 3. Department of Psychiatry Faculty of Medicine, Van Yüzüncü Yıl University Van Turkey; 4. Department of Psychiatric and Mental Health Nursing, Faculty of Nursing Koc University Istanbul Turkey展开收起
222
天
Cortical Thickness in Middle and Older Aged Adults With Bipolar Disorder Across Six International Sites
作者
Rebecca Marks; Anjali Sankar; Lejla Colic; Jair Soares; Joaquim Radua; Eduard Vieta; Benson Mwangi; Mon‐Ju Wu; Enric Vilajosana; Edith Pomarol‐Clotet; Erick Canales‐Rodríguez; Raymond Salvador; Brian Pittman; Annemieke Dols; Martha Sajatovic; Lisa T. Eyler; Hilary P. Blumberg展开收起
作者单位
1. Department of Psychiatry Yale School of Medicine New Haven USA; 2. Western Psychiatric Hospital University of Pittsburgh Medical Center Pittsburgh USA; 3. Neurobiology Research Unit Copenhagen University Hospital Copenhagen Denmark; 4. Department of Psychiatry and Psychotherapy Jena University Hospital Jena Germany; 5. German Center for Mental Health, Partner Site Halle‐Jena‐Madgeburg Madgeburg Germany; 6. Department of Psychiatry University of Texas Health Science Center Houston USA; 7. Institut D'investigacio Biomedica August Pi I Sunyer, IDIBAPS Barcelona Spain; 8. Institute of Neuroscience, University of Barcelona Barcelona Catalonia Spain; 9. Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM) Madrid Spain; 10. Department of Psychiatry and Psychology Hospital Clinic de Barcelona Barcelona Spain; 11. FIDMAG Germanes Hospitalàries Sant Boi del Llobregat Spain; 12. Department of Psychiatry University Medical Center Utrecht, Utrecht University Utrecht the Netherlands; 13. Department of Psychiatry Case Western Reserve University School of Medicine Cleveland USA; 14. Department of Psychiatry University of California San Diego San Diego USA展开收起
Expert Matching · Case Demo
把投稿要求，转成可验证的期刊方案
说清专业、时限和作者背景，CrushSCI 结合真实审稿样本，给出拟题方向、期刊初筛与周期判断。
客户询问
我是环境工程专业，需要一篇 SCI，希望 3 个月内见刊。没有基金，也没有大牛挂名，可以投哪些期刊？
CrushSCI回复
可以。先按 90 天时限做可行性筛选，同步查找无基金、无知名作者挂靠的典型论文案例，作为选刊依据。重点核对研究质量与期刊 scope。
- 拟题建议
- 《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》
样本口径2026 年最近 5 篇有效论文样本
平均审稿62 天
中位数65 天